Brookfield Asset Management Inc. Vaccitech PLC Transaction History

Brookfield Asset Management Inc.

  • $15.2 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$14.0 - $16.5 $127,106 - $149,803
-9,079 Reduced 36.32%
15,921 $250,000
Q2 2021

Aug 17, 2021
BUY
$13.03 - $17.0 $325,750 - $425,000
25,000 New
25,000 $419,000

About Vaccitech plc

VACC Quotes by TradingView
  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email